Litcius/Paper detail

Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response

Yan Mei, Xiumei Wang, Ji Zhang, Dan Liu, Junjie He, Chunliu Huang, Jing Liao, Yingzhao Wang, Yong-Yi Feng, Hongyu Li, Xiuying Liu, Lingdan Chen, Yi Wei, Xi Chen, Hongmin Bai, Xinyu Wang, Yiyi Li, Lixiang Wang, Zhigang Liang, Xianwen Ren, Qiu Li, Hui Yuan, Qingling Zhang, Qibin Leng, Jun Chen, Guangshuai Jia

2023Nature Cancer221 citationsDOI

Topics & Concepts

Cancer researchImmunotherapyImmune checkpointImmune systemCD8T cellBlockadeChemokineCytotoxic T cellPriming (agriculture)BiologyDendritic cellMyeloidImmunologyReceptorGerminationIn vitroBotanyBiochemistryImmune cells in cancerSingle-cell and spatial transcriptomicsGlioma Diagnosis and Treatment